Effects of adolescent caffeine consumption on cocaine sensitivity

Neuropsychopharmacology

Volumn 40, Issue 4, 2015, Pages 813-821

  O'Neill, Casey E ^a   Levis, Sophia C ^a   Schreiner, Drew C ^a   Amat, Jose ^a   Maier, Steven F ^a   Bachtell, Ryan K ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CAFFEINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; QUINPIROLE; SUCROSE; ADENOSINE A2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONDITIONING; CONTROLLED STUDY; DOPAMINE RELEASE; FOOD INTAKE; FOOD PREFERENCE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REWARD; SENSITIVITY ANALYSIS; SENSITIZATION; AGE; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; INSTRUMENTAL CONDITIONING; METABOLISM; SPRAGUE DAWLEY RAT;

AGE FACTORS; ANIMALS; CAFFEINE; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FOOD PREFERENCES; GENE EXPRESSION REGULATION; HUMANS; LOCOMOTION; MALE; NUCLEUS ACCUMBENS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; RECEPTORS, DOPAMINE D2;

EID: 84925533101     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.278     Document Type: Article

References (44)

1. Bachtell RK, Whisler K, Karanian D, Self DW (2005). Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology 183: 41-53.
2. Bedingfield JB, King DA, Holloway FA (1998). Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol Biochem Behav 61: 291-296.
3. Bello EP, Mateo Y, Gelman DM, Noain D, Shin JH, Low MJ et al (2011). Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14: 1033-1038.
4. Boeck CR, Marques VB, Valvassori SS, Constantino LC, Rosa DV, Lima FF et al (2009). Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. Neurochem Int 55: 318-322.
5. Borycz J, Pereira MF, Melani A, Rodrigues RJ, Kofalvi A, Panlilio L et al (2007). Differential glutamate-dependent and glutamateindependent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J Neurochem 101: 355-363.
6. Brodnik Z, Double M, Jaskiw GE (2013). Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion. Psychopharmacology 227: 363-371.
7. Carroll ME, Lac ST (1998). Dietary additives and the acquisition of cocaine self-administration in rats. Psychopharmacology 137: 81-89.
8. De Luca MA, Bassareo V, Bauer A, Di Chiara G (2007). Caffeine and accumbens shell dopamine. J Neurochem 103: 157-163.
9. Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S et al (1999). Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res 73: 37-49.
10. Ebstein RP, Daly JW (1982). Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues. Cell Mol Neurobiol 2: 193-204.
11. Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991). Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88: 7238-7241.
12. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A et al (1998). DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281: 838-842.
13. Filip M, Frankowska M, Zaniewska M, Przegalinski E, Muller CE, Agnati L et al (2006). Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine. Brain Res 1077: 67-80.
14. Fontana D, Post RM, Weiss SR, Pert A (1993). The role of D1 and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior. Behav Pharmacol 4: 375-387.
15. Frary CD, Johnson RK, Wang MQ (2005). Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105: 110-113.
16. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133.
17. Fuxe K, Ferre S, Genedani S, Franco R, Agnati LF (2007). Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 92: 210-217.
18. Garrett BE, Holtzman SG (1994). D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav 47: 89-94.
19. Gasior M, Jaszyna M, Peters J, Goldberg SR (2000). Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. J Pharmacol Exp Ther 295: 1101-1111.
20. Gladwin TE, Figner B, Crone EA, Wiers RW (2011). Addiction, adolescence, and the integration of control and motivation. Dev Cogn Neurosci 1: 364-376.
21. Herrera-Marschitz M, Casas M, Ungerstedt U (1988). Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology 94: 38-45.
22. Horger BA, Wellman PJ, Morien A, Davies BT, Schenk S (1991). Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2: 53-56.
23. Jin S, Johansson B, Fredholm BB (1993). Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J Pharmacol Exp Ther 267: 801-808.
24. Kendler KS, Myers J, O Gardner C (2006). Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 36: 1717-1725.
25. Marin MT, Zancheta R, Paro AH, Possi AP, Cruz FC, Planeta CS (2011). Comparison of caffeine-induced locomotor activity between adolescent and adult rats. Eur J Pharmacol 660: 363-367.
26. Merritt KE, Bachtell RK (2013). Initial d2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats. PLoS One 8: e78258.
27. Miller KE (2008). Energy drinks, race, and problem behaviors among college students. J Adolesc Health 43: 490-497.
28. Misra AL, Vadlamani NL, Pontani RB (1986). Effect of caffeine on cocaine locomotor stimulant activity in rats. Pharmacol Biochem Behav 24: 761-764.
29. Nehlig A, Daval JL, Boyet S (1994). Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain. Eur J Pharmacol 258: 57-66.
30. O'Neill CE, Hobson BD, Levis SC, Bachtell RK (2014). Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A and A receptors during extinction training in rats. Psychopharmacology 231: 3179-3188.
31. Pfeifer JH, Masten CL, Moore WE 3rd, Oswald TM, Mazziotta JC, Iacoboni M et al (2011). Entering adolescence: resistance to peer influence, risky behavior, and neural changes in emotion reactivity. Neuron 69: 1029-1036.
32. Rath M (2012). Energy drinks: what is all the hype? The dangers of energy drink consumption. J Am Acad Nurse Pract 24: 70-76.
33. Rhoads DE, Huggler AL, Rhoads LJ (2011). Acute and adaptive motor responses to caffeine in adolescent and adult rats. Pharmacol Biochem Behav 99: 81-86.
34. Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E et al (2008). Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105: 4405-4410.
35. Schenk S, Horger B, Snow S (1990). Caffeine preexposure sensitizes rats to the motor activating effects of cocaine. Behav Pharmacol 1: 447-451.
36. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996). Opposite modulation of cocaine-seeking behavior by D1-and D2-like dopamine receptor agonists. Science 271: 1586-1589.
37. Solinas M, Ferre S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR (2002). Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22: 6321-6324.
38. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
39. Temple JL (2009). Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev 33: 793-806.
40. Vanattou-Saifoudine N, Gossen A, Harkin A (2011). A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA 'Ecstasy'-induced striatal dopamine release. Eur J Pharmacol 650: 220-228.
41. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR et al (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
42. Wu J, Lee MR, Choi S, Kim T, Choi DS (2010). ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 34: 1110-1117.
43. Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F et al (2002). Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biol Psychiatry 51: 612-620.
44. Zetterstrom T, Fillenz M (1990). Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur J Pharmacol 180: 137-143.